secwatch.observer — SEC 8-K summary
======================================

Issuer:     AYTU BIOPHARMA, INC (AYTU)
CIK:        0001385818
Form:       8-K
Filed at:   2023-10-06T23:59:59+00:00
Accession:  0001558370-23-016284
Event type: leadership
Sentiment:  negative
Materiality: 0.80
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Aytu BioPharma COO resigns; company winding down manufacturing, suspending R&D
------------------------------------------------------------------------------

- COO Christopher Brooke resigned effective Oct 13, 2023, to join a development-stage biotech.
- Company will not replace COO due to wind down of manufacturing at Grand Prairie, TX facility.
- All pipeline research and development programs are indefinitely suspended.
- Resignation not due to any disagreement with company or auditors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1385818/000155837023016284/0001558370-23-016284-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1385818/000155837023016284/aytu-20231003x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-016284

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer